APA (7th ed.) Citation

Idoate, M. A., Ariz-Galilea, M., Urbiola-Casales, A., Alonso-García, M., Machuca-Aguado, J., Ortiz de Solórzano, C., . . . Biscuola, M. (2025). Immune Scenario Identification Combining Multiplexed, Quantitative, and Advanced Imaging Analysis Could Be Relevant in Immunotherapy against Glioblastoma and Grade 4 Astrocytoma. Pathobiology, 92(6), 315. https://doi.org/10.1159/000545488

Chicago Style (17th ed.) Citation

Idoate, Miguel A., Mikel Ariz-Galilea, Ainhoa Urbiola-Casales, Miriam Alonso-García, Jesús Machuca-Aguado, Carlos Ortiz de Solórzano, Eloy Rivas-Infante, Rainiero Avila-Polo, and Michele Biscuola. "Immune Scenario Identification Combining Multiplexed, Quantitative, and Advanced Imaging Analysis Could Be Relevant in Immunotherapy Against Glioblastoma and Grade 4 Astrocytoma." Pathobiology 92, no. 6 (2025): 315. https://doi.org/10.1159/000545488.

MLA (9th ed.) Citation

Idoate, Miguel A., et al. "Immune Scenario Identification Combining Multiplexed, Quantitative, and Advanced Imaging Analysis Could Be Relevant in Immunotherapy Against Glioblastoma and Grade 4 Astrocytoma." Pathobiology, vol. 92, no. 6, 2025, p. 315, https://doi.org/10.1159/000545488.